drugset / Trial / NCT02749409

Early Parecoxib Usage to Decreases Narcotic Requirement and Length of Stay After Traumatic Rib Fracture

NCT02749409 ↗

Phase 3 Terminated 17 enrolled Chang Gung Memorial Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

Patients diagnosed traumatic rib fracture and need admission will be included. Patients will be divided two groups.The experimental group will be given parecoxib after visiting emergency department. The control group will be given Narcotic agent such as morphine for pain control. The outcome such as numerical rating scale (NRS) and hospital length of stay will be recorded.

Timeline

Start
2016-08-08
Primary completion
2018-07-10
Completion
2018-07-20

Outcome

Outcome not reported

Stopped (Business): “Case numbers not enough, however, the funding is over”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Morphine Other / unclassified — —
Subject Parecoxib Small molecule — Intravenous

Indications

No indication recorded.